Oncodesign Services is a leading CRO specialized in drug discovery. With its unique experience acquired by working with more than 1,000 clients along with its comprehensive technological platform combining state-of-the-art medicinal chemistry, pharmacology, bioanalysis (GLP), & pharmaco-imaging, Oncodesign Services orients, drives & executes the development of drug candidates from hit findings up to IND. Based in Dijon, France, Oncodesign Services has 227 employees in France, Canada and the United States. Oncodesign Services has specialties in imaging and molecular radiotherapies (MRT). We are able to understand the pharmacology and efficacy of your molecule using non-invasive methods. We can, now propose you a large and integrated spectrum of expertise in nuclear medicine covering the entire Drug Discovery process specialized in targeted systemic radiotherapy (Theranostics) ; from the generation of radio-labeled biological vectors, the opt
Press Releases
-
Debiopharm and Oncodesign Services Launch Strategic Collaboration to Propel Radiopharmaceuticals in Preclinical Research
AbYlink™ is a regio-selective bioconjugation technology ideally suited for preparing conjugates for use in therapeutic and non-invasive diagnostic applications. Oncodesign Services will use this cutting-edge technology to prepare antibody chelator conjugates for use in preclinical studies to gain insights into the predictive effectiveness of novel treatment approaches in Molecular Radiotherapy, and particularly Radioimmunotherapy in the context of cancer.